CBL0137
| CAS No. | 1197996-80-7 | Cat. No. | BCP29977 |
| Name | CBL0137 | ||
| Synonyms | CBL-0137; CBL 0137; Curaxin 137; | ||
| Formula | C21H24N2O2 | M. Wt | 336.43 |
| Description | CBL0137, also known as Curaxin 137, is a metabolically stable curaxin that activates p53 with an EC50 value of 0.37 µM and inhibits NF-κB with an EC50 of 0.47 µM. CBL0137 inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and -resistant glioblastoma. CBL0137 eradicates drug resistant cancer stem cells and potentiates efficacy of gemcitabine in preclinical models of pancreatic cancer. | ||
| Pathways | Apoptosis Pathway NFκB | ||
| Targets | NF κB c Myc p53 | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.